Penserra Capital Management LLC Syndax Pharmaceuticals Inc Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$15.23 - $22.47 $16,981 - $25,054	-1,115 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.87 - $19.8 $208 - $297	15 Added 1.36%	1,115 $21,000
Q2 2021 Aug 12, 2021	BUY	$13.42 - $25.18 $469 - $881	35 Added 3.29%	1,100 $18,000
Q1 2021 May 13, 2021	BUY	$19.28 - $24.59 $2,410 - $3,073	125 Added 13.3%	1,065 $23,000
Q4 2020 Feb 12, 2021	BUY	$15.1 - $26.44 $14,194 - $24,853	940 New	940 $20,000

228

88.4M

1.01M

692K

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $796M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.